AMELIORATIVE EFFECT OF NARINGENIN AGAINST ANTITUBERCULOSIS DRUGS INDUCED ALTERATIONS IN HEMATOLOGICAL PARAMETERS OF RATS

Authors

  • Nisha Sahu Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.
  • Gita Mishra Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.
  • Hemeshwer Kumar Chandra Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.
  • Satendra Kumar Nirala Department of Rural Technology and Social Development, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.
  • Monika Bhadauria Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i11.27563

Keywords:

Antituberculosis drugs, Naringenin, Hematological parameters, Rats

Abstract

Objective: The aim of the present study was to evaluate the efficacy of naringenin against antituberculosis drugs (ATDs) induced alteration in hematological parameters in rats.

Methods: Rats were administered with ATDs for 8 weeks (3 days/weeks) followed by naringenin at three different doses (10, 20, and 40 mg/kg) conjointly for 8 weeks (3 days/weeks) orally. After 8 weeks, animals were euthanized; blood was collected by retro-orbital sinus method for the analysis of hematological parameters.

Results: The results of this study show decreased in red blood cells, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets, and eosinophils along with increase in the number of lymphocytes in ATDs induced rats. Treatment with naringenin encountered ATDs induced hematological parameter alteration which was evident by significant reversal in hematological indices toward control in dose-dependent manner.

Conclusion: The present study concluded that ATDs exposure caused adverse effects in various blood components and conjoint treatment of naringenin reduced hematological alterations toward control due to antioxidant activity.

Downloads

Download data is not yet available.

Author Biography

Nisha Sahu, Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur - 495 009, Chhattisgarh, India.

Dr. Monika Bhadauria

Associate Professor
Department of Zoology
Guru Ghasidas Vishwavidyalaya
Bilaspur, Chhattisgarh

References

World Health Organization. Global Tuberculosis Report; 2017.

Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R, et al. Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J Gastroenterol Hepatol 2008;23:192-202.

Arbex MA, Varella Mde C, Siqueira HR, Mello FA. Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations. Part 2: Second line drugs. J Bras Pneumol 2010;36:641-56.

Chrestella JM, Ginting MA, Dalimunthe A, Nasuton R. Hepatoprotective activity combination of Curanga fel-terrae lour leaves and Curcuma heyneana valeton and Zijprhizhome in rat induced by combination of rifampicin and isoniazid. Int J Pharm Pharm Sci 2017;9:23-8.

Buntoro IF, Sumardi KE. Decrease of liver function after treatment of antituberculosis drugs in tuberculosis patients with malnutrition and alcohol consumption. Int J Pharm Pharm Sci 2016;8:269-37.

Kapoor R, Kakkar P. Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade. Toxicol Rep 2014;1:569- 81.

Tripoli E, La Guardia M, Giammanco S, Di Majo D, Giammanco M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem 2007;104:466-79.

Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, et al. Comparison of antioxidant effects of Naringin and probucol in cholesterol-fed rabbits. Clin Chim Acta 2002;317:181-90.

Yi LT, Li J, Li HC, Su DX, Quan XB, He XC, Wang XH. Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test. Prog Neuro Psycho Pharmacol Biol Psychiatry 2012;39(1):175-81.

Yoshida H, Watanabe W, Oomagari H, Tsuruta E, Shida M, Kurokawa M, et al. Citrus flavonoid Naringenin inhibits TLR2 expression in adipocytes. J Nutr Biochem 2013;24:1276-84.

Renugadevi J, Prabu SM. Cadmium-induced hepatotoxicity in rats and the protective effect of Naringenin. Exp Toxicol Pathol 2010;62:171- 81.

Renugadevi J, Prabu SM. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 2009;256:128-34.

Riley V. Adaptation of orbital bleeding technic to rapid serial blood studies. Proc Soc Exp Biol Med 1960;104:751-4.

Gupta SC. Fundamentals of Statistics. 7th ed. New Delhi: Himalaya Publishing House; 2012. p. 19.1-36.

Etim NN, Williams ME, Akpabio U, Offiong EE. Haematological parameters and factors affecting their values. J Agric Sci 2014;2:37-7.

Kassa E, Enawgaw B, Gelaw A, Gelaw B. Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at university of gondar hospital, northwest ethiopia. BMC Hematol 2016;16:1.

Bharti U, Kumar NR, Kaur J. Ameliorating effect of bee pollen against anti-tuberculosis drugs (Rifampicin and Isoniazid) induced toxicity on hematology of Sprague dawley rats. Asian J Pharm Clin Res 2017;10:188-90

Chineke CA, Ologun AG, Ikeobi CO. Haematological parameters in rabbit breeds and crosses in humid tropics. Pak J Biol Sci 2006;9:2102- 6.

Wong PC, Yew WW, Wong CF, Choi HY. Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement. Eur Respir J 1995;8:866-68.

Lange P, Oun H, Fuller S, Turney JH. Eosinophilic colitis due to rifampicin (letter). Lancet 1994;344:1296-7.

Al-Roujayee AS. Naringenin improves the healing process of thermally-induced skin damage in rats. J Int Med Res 2017;45:570-82.

Published

07-11-2018

How to Cite

Sahu, N., G. Mishra, H. Kumar Chandra, S. Kumar Nirala, and M. Bhadauria. “AMELIORATIVE EFFECT OF NARINGENIN AGAINST ANTITUBERCULOSIS DRUGS INDUCED ALTERATIONS IN HEMATOLOGICAL PARAMETERS OF RATS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 11, Nov. 2018, pp. 253-5, doi:10.22159/ajpcr.2018.v11i11.27563.

Issue

Section

Original Article(s)

Most read articles by the same author(s)